TD Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$445K Buy
5,215
+5,009
+2,432% +$453K 0.04% 95
2026
Q2
$18.9K Buy
206
+1
+0.5% +$87 ﹤0.01% 372
2026
Q1
$17.5K Sell
205
-121
-37% -$10.8K ﹤0.01% 387
2025
Q4
$25.7K Buy
326
+124
+61% +$9.7K ﹤0.01% 316
2025
Q3
$16.2K Buy
202
+1
+0.5% +$85 ﹤0.01% 360
2025
Q2
$18.3K Buy
+201
New +$18.4K ﹤0.01% 331
2013
Q4
– Sell
-1,871
Closed -$111K – 159
2013
Q3
$111K Buy
1,871
+1
+0.1% +$59 0.03% 82
2013
Q2
$107K Buy
+1,870
New +$111K 0.03% 80

Other funds holding CL

TD Capital Management's CL Position: Q3 2026 in Review

TD Capital Management increased its Colgate-Palmolive (CL) stake by 2,432% in Q3 2026, buying an estimated $453K and bringing the position to 5,215 shares worth $445K. The position accounts for 0.04% of the portfolio, ranked #95.

TD Capital Management first reported a position in CL in Q2 2013 and has held it in 8 quarters since. 1,322 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • TD Capital Management held 5,215 shares of Colgate-Palmolive worth $445K as of Q3 2026.
  • TD Capital Management bought 5,009 Colgate-Palmolive shares in Q3 2026, an estimated $453K.
  • Colgate-Palmolive made up 0.04% of TD Capital Management's portfolio in Q3 2026, its #95 holding.
  • TD Capital Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 8 quarters since.
  • 1,322 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on TD Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.